TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8541734

Group type: EXPERIMENTAL
Intervention: Modified Senning procedure (group 2)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Conventional method (group 1)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 10
Study: 1975780

Group type: EXPERIMENTAL
Intervention: Nisoldipine (2 X 10 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Captopril (3 X 25 mg)
Number of subjects: 24
Study: 394864

Group type: EXPERIMENTAL
Intervention: 12 cycles of adjuvant CMF
Number of subjects: 325

Group type: COMPARATOR
Intervention: 6 cycles of adjuvant CMF
Number of subjects: 325
Study: 30091141

Group type: EXPERIMENTAL
Intervention: M‐Wire Reciproc
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Reciproc Blue
Number of subjects: 20

Group type: COMPARATOR
Intervention: M‐Wire Reciproc and Reciproc Blue (combined)
Number of subjects: 20
Study: 27984226

Group type: EXPERIMENTAL
Intervention: Lidocaine (20 mL 2% lidocaine with epinephrine)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Placebo (20 mL normal saline)
Number of subjects: 204
Study: 26367003

Group type: EXPERIMENTAL
Intervention: 1μg LPS
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 10μg LPS
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 30μg LPS
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 100μg LPS
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 24015696

Group type: EXPERIMENTAL
Intervention: Fruit/Veggie Juice Powder (FV)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Fruit/Veggie/Berry Juice Powder (FVB)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Fruit/Veggie Juice Powder (FV) and Fruit/Veggie/Berry Juice Powder (FVB)
Number of subjects: 75
Study: 21273491

Group type: EXPERIMENTAL
Intervention: Insulin requirements during high altitude trekking
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Glucose levels during high altitude trekking
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Insulin doses at altitudes >5,000 m
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Glucose levels at altitudes >5,000 m
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: AMS scores at altitudes >5,000 m
Number of subjects: 8

Group type: COMPARATOR
Intervention: Energy expenditure and AMS symptoms comparison
Number of subjects: 8
Study: 19190034

Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 88

Group type: COMPARATOR
Intervention: Brief supportive therapy
Number of subjects: 88
Study: 17080587

Group type: EXPERIMENTAL
Intervention: Transdermal continuous hormone replacement therapy (HRT) with estradiol 50 microg/day and norethisterone acetate 140 microg/day (Estalis)
Number of subjects: 406

Group type: COMPARATOR
Intervention: Oral hormone replacement therapy (HRT) with estradiol 2 mg and norethisterone acetate 1 mg (Kliogest)
Number of subjects: 406
Study: 14769753

Group type: EXPERIMENTAL
Intervention: Nebulized opioids (morphine, hydromorphone)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo (not explicitly mentioned but implied as control)
Number of subjects: 65
Study: 11443567

Group type: EXPERIMENTAL
Intervention: Endotoxin and ibuprofen
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Soluble tumor necrosis factor receptor
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Soluble interleukin-1 receptor
Number of subjects: 52
Study: 9446349

Group type: EXPERIMENTAL
Intervention: Patients operated for malignant neoplasm
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Patients with inflammatory changes and purulent complications
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Patients operated from other indications
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group of healthy volunteers
Number of subjects: 57
Study: 7969244

Group type: EXPERIMENTAL
Intervention: Facial action myoclonus patients
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Patients with OPCA without facial action myoclonus
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Patients with pure cerebellar cortical atrophy
Number of subjects: 17

Group type: COMPARATOR
Intervention: Normal volunteers (control)
Number of subjects: 17
Study: 2958817

Group type: EXPERIMENTAL
Intervention: Depilatory agent (group II)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Shaving (group I)
Number of subjects: 100
Study: 29669668

Group type: EXPERIMENTAL
Intervention: GSP301 (olopatadine 665 μg - mometasone 50 μg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: MF-sponsor (mometasone 50 μg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: MF (mometasone 50 μg)
Number of subjects: 30
Study: 26198280

Group type: EXPERIMENTAL
Intervention: 20 G vitrectomy and circumferential scleral buckling (E1)
Number of subjects: 257

Group type: COMPARATOR
Intervention: 20 G vitrectomy alone (C)
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: 23/25 G vitrectomy alone (E2)
Number of subjects: 257
Study: 24371264

Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study: 22509949

Group type: EXPERIMENTAL
Intervention: Tiotropium treatment
Number of subjects: 30
Study: 21120304

Group type: EXPERIMENTAL
Intervention: Laser therapy (5 joule/cm² at each point over maximum 5‐6 painful points for 1 minute)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo laser therapy
Number of subjects: 52
Study: 18341614

Group type: EXPERIMENTAL
Intervention: Interferon (IFN)-beta
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Atorvastatin + Interferon (IFN)-beta
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 0
Study: 16449522

Group type: EXPERIMENTAL
Intervention: 6-methylprednisolone (6MPred) 2 mg/kg per day for 5 consecutive days
Number of subjects: 211

Group type: COMPARATOR
Intervention: 6MPred 5 mg/kg per day for 10 days
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: 6MPred 5 mg/kg per day for 10 days + rabbit anti-thymocyte globulin (ATG, 6.25 mg/kg in 10 days)
Number of subjects: 211
Study: 15804077

Group type: EXPERIMENTAL
Intervention: 1% CsA and 0.1% dexamethasone for 3 months
Number of subjects: 86

Group type: COMPARATOR
Intervention: 1% CsA for 3 months
Number of subjects: 86

Group type: COMPARATOR
Intervention: 0.1% dexamethasone for 3 months
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Sub-conjunctiva injection of dexamethasone combined with eye drops of 1% CsA and 0.1% dexamethasone
Number of subjects: 86
Study: 10959781

Group type: EXPERIMENTAL
Intervention: 0.5% KTP gel
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 1.0% KTP gel
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 1.0% KTP alternate gel
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 2.0% KTP gel
Number of subjects: 42

Group type: COMPARATOR
Intervention: 25 mg KTP capsule (positive control)
Number of subjects: 42
Study: 8911891

Group type: EXPERIMENTAL
Intervention: Human chorionic gonadotropin (twice‐weekly intramuscular injections for 5 weeks; total dose 2500 IU for patients less than 1‐year‐old, 5000 IU for 1‐ to 6‐year‐olds, 10000 IU for 6‐ to 11‐year‐olds)
Number of subjects: 310

Group type: COMPARATOR
Intervention: Inguinal herniography (to detect patent vaginal process)
Number of subjects: 310
Study: 1529280

Group type: EXPERIMENTAL
Intervention: Cisapride, 10 mg three times daily for 14 days
Number of subjects: 106

Group type: COMPARATOR
Intervention: Placebo for 14 days
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Cisapride
Number of subjects: 106
Study: 6732212

Group type: EXPERIMENTAL
Intervention: Rifampin (600 mg once a day for 5 days)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Bacitracin ointment (topically applied three times a day for 10 days)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Combined rifampin and bacitracin
Number of subjects: 132

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 132
Study: 30925824

Group type: EXPERIMENTAL
Intervention: Rice bran supplement containing PRB (43 μg LRA/day)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 100
Study: 29960358

Group type: EXPERIMENTAL
Intervention: Machine learning-based screening using a grammar variational autoencoder
Number of subjects: 3989

Group type: COMPARATOR
Intervention: Randomised search
Number of subjects: 3989
Study: 27711199

Group type: EXPERIMENTAL
Intervention: Sitagliptin
Number of subjects: 103

Group type: COMPARATOR
Intervention: Glimepiride
Number of subjects: 103
Study: 25366674

Group type: EXPERIMENTAL
Intervention: Gynocular (used by nurses)
Number of subjects: 932

Group type: EXPERIMENTAL
Intervention: Stationary colposcope (used by nurses)
Number of subjects: 932

Group type: COMPARATOR
Intervention: Gynocular (used by doctors)
Number of subjects: 932

Group type: COMPARATOR
Intervention: Stationary colposcope (used by doctors)
Number of subjects: 932

Group type: COMPARATOR
Intervention: Biopsy
Number of subjects: 932
Study: 23059159

Group type: EXPERIMENTAL
Intervention: BL-1020 20-30 mg/d
Number of subjects: 363

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: Risperidone (2-8 mg/d)
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: BL-1020 10 mg/d
Number of subjects: 363
Study: 19937166

Group type: EXPERIMENTAL
Intervention: Surgical navigation
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional jig‐based technique
Number of subjects: 80
Study: 18832540

Group type: EXPERIMENTAL
Intervention: Peer teaching intervention for physicians
Number of subjects: 870

Group type: COMPARATOR
Intervention: Control group (standard practice)
Number of subjects: 870
Study: 16055579

Group type: EXPERIMENTAL
Intervention: Continuous infusion of 0.125% bupivacaine with 2 microg/mL fentanyl at a rate of 8 mL/h (group A)
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Intermittent bolus of 10 mL of 0.25% bupivacaine on demand (group B)
Number of subjects: 190

Group type: COMPARATOR
Intervention: No epidural analgesia (group C)
Number of subjects: 190
Study: 12449445

Group type: EXPERIMENTAL
Intervention: Eicosapentaenoic acid (EPA) 1800 mg/day
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Eicosapentaenoic acid (EPA)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control (no EPA)
Number of subjects: 15
Study: 10609824

Group type: EXPERIMENTAL
Intervention: Meal high in monounsaturated fat
Number of subjects: 0

Group type: COMPARATOR
Intervention: Carbohydrate-rich meal
Number of subjects: 0
Study: 7815886

Group type: EXPERIMENTAL
Intervention: Expectant management
Number of subjects: 155

Group type: COMPARATOR
Intervention: D&C
Number of subjects: 155
Study: 1833042

Group type: EXPERIMENTAL
Intervention: Cisplatin, high-dose cytosine arabinoside, and caffeine (CAC)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Streptozotocin, mitomycin, and 5-fluorouracil (SMF)
Number of subjects: 82
Study: 6120313

Group type: EXPERIMENTAL
Intervention: Single oral immunisation with cholera B subunit
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single intramuscular immunisation with cholera B subunit
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Second immunisation by either route (oral or intramuscular)
Number of subjects: 0
Study: 30638065

Group type: EXPERIMENTAL
Intervention: CBT-plus-fluoxetine
Number of subjects: 0

Group type: COMPARATOR
Intervention: CBT-plus-placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: CBT-only
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 0
Study: 29290563

Group type: EXPERIMENTAL
Intervention: Ventilator-piloted pulmonary recruitment maneuver (PRM)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Routine exsufflation (control group)
Number of subjects: 150
Study: 26804640

Group type: EXPERIMENTAL
Intervention: Single oral dose of 25 mg of cinacalcet
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Single oral dose of 50 mg of cinacalcet
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Single oral dose of 100 mg of cinacalcet
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Multiple doses of 50 mg of cinacalcet once daily for 7 days
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Cinacalcet administration (single and multiple doses)
Number of subjects: 42
Study: 24629181

Group type: EXPERIMENTAL
Intervention: Rocker-sole footwear (MBT® Matwa, Masai Barefoot Technology, Switzerland)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Individualised prefabricated foot orthoses (Vasyli Customs, Vasyli Medical™, Queensland, Australia)
Number of subjects: 80
Study: 22353201

Group type: EXPERIMENTAL
Intervention: S-1 at 25 mg twice daily for 5 days (level 1)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: S-1 at 40 mg twice daily for 5 days (level 2)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 12
Study: 20584700

Group type: EXPERIMENTAL
Intervention: Placement of the alcohol-based hand-rub dispenser in clear view of physicians
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placement of the alcohol-based hand-rub dispenser not in the field of view
Number of subjects: 52
Study: 17393237

Group type: EXPERIMENTAL
Intervention: Inhaled budesonide and formoterol
Number of subjects: 36
Study: 15538607

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 190

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 190
Study: 11350520

Group type: EXPERIMENTAL
Intervention: Braun Oral‐B 3D Plaque Remover (3D)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Braun Oral‐B D9
Number of subjects: 40

Group type: COMPARATOR
Intervention: Philips/Jordan HP 735
Number of subjects: 40
Study: 10346658

Group type: EXPERIMENTAL
Intervention: Culturally sensitive nutrition intervention for 3 months
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 18
Study: 8036887

Group type: EXPERIMENTAL
Intervention: 500 IU/r‐IL‐2/day
Number of subjects: 22

Group type: COMPARATOR
Intervention: 500,000 IU/r‐IL‐2/day
Number of subjects: 22
Study: 3289861

Group type: EXPERIMENTAL
Intervention: Topical hyperbaric oxygen (THO) treatment for 2 weeks
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (no THO treatment)
Number of subjects: 28
Study: 31181564

Group type: EXPERIMENTAL
Intervention: Memantine
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 28645969

Group type: EXPERIMENTAL
Intervention: Motivational training (experimental arm)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control arm (no motivational training)
Number of subjects: 14
Study: 26244877

Group type: EXPERIMENTAL
Intervention: ADT plus docetaxel (75 mg/m² every 3 weeks for six cycles)
Number of subjects: 790

Group type: COMPARATOR
Intervention: ADT alone
Number of subjects: 790

Group type: EXPERIMENTAL
Intervention: ADT plus docetaxel
Number of subjects: 790
Study: 24195207

Group type: EXPERIMENTAL
Intervention: Acupuncture + medication (SSRIs)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Medication (SSRIs)
Number of subjects: 90
Study: 21383112

Group type: EXPERIMENTAL
Intervention: Psychoeducational individual program
Number of subjects: 111

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 111
Study: 19321522

Group type: EXPERIMENTAL
Intervention: Forced use group (wore a restraining sling on the non-paretic arm for up to 6 hours per weekday for two weeks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional group (participated in two weeks of daily training on weekdays)
Number of subjects: 30
Study: 15889626

Group type: EXPERIMENTAL
Intervention: Behavioral parenting skills training, social skills training, and supplemental reading instruction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 0
Study: 10516943

Group type: EXPERIMENTAL
Intervention: Indinavir sulfate 400 mg orally every 6 hours with placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: TMP 160 mg/SMZ 800 mg orally every 12 hours with placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Indinavir sulfate with TMP/SMZ
Number of subjects: 12
Study: 7586112

Group type: EXPERIMENTAL
Intervention: Succinylcholine 1 mg.kg‐1 (SxCh)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Vecuronium 0.3 mg.kg‐1 (Vec 0.3)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Vecuronium 0.5 mg.kg‐1 (Vec 0.5)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Vecuronium 0.5 mg.kg‐1 (Vec 0.5) in beta blocker group
Number of subjects: 60
Study: 2149512

Group type: EXPERIMENTAL
Intervention: Isradipine (2.5-10 mg bid)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Prazosin (2-8 mg bid)
Number of subjects: 83
Study: 6118248

Group type: EXPERIMENTAL
Intervention: Ranitidine (acid-inhibitory and non-acid-inhibitory dosages)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Ranitidine (various doses)
Number of subjects: 18
Study: 31822689

Group type: EXPERIMENTAL
Intervention: Hybrids 'Xianyu335' and 'Zhengdan958' at 150 kg N ha‐1
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Hybrids 'Xianyu335' and 'Zhengdan958' at 0 kg N ha‐1
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Hybrids 'Xianyu335' and 'Zhengdan958'
Number of subjects: 4
Study: 30280946

Group type: EXPERIMENTAL
Intervention: CE 0.45 mg/BZA 20 mg
Number of subjects: 1596

Group type: EXPERIMENTAL
Intervention: CE 0.625 mg/BZA 20 mg
Number of subjects: 1596

Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 1596

Group type: COMPARATOR
Intervention: CE 0.45 mg/MPA 1.5 mg
Number of subjects: 1596

Group type: EXPERIMENTAL
Intervention: CE/BZA doses and Placebo
Number of subjects: 1596
Study: 27267151

Group type: EXPERIMENTAL
Intervention: Mindfulness meditation (MM) intervention combined with usual care
Number of subjects: 35

Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 35
Study: 25138548

Group type: EXPERIMENTAL
Intervention: High-resolution computed tomography (HRCT)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Exhaled nitric oxide (FENO)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Biological markers in induced sputum (MMP-9 and TIMP-1)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Neutrophilia in sputum
Number of subjects: 34
Study: 22743565

Group type: EXPERIMENTAL
Intervention: Erythropoietin analog treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 19148406

Group type: EXPERIMENTAL
Intervention: InCeram Zirconia crowns
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cercon Zirconia crowns
Number of subjects: 20

Group type: COMPARATOR
Intervention: Both InCeram and Cercon Zirconia crowns
Number of subjects: 20
Study: 17444313

Group type: EXPERIMENTAL
Intervention: Intersurgical Scented mask
Number of subjects: 30

Group type: COMPARATOR
Intervention: Black rubber mask
Number of subjects: 30
Study: 16323386

Group type: EXPERIMENTAL
Intervention: Home exercise program (n = 15)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (n = 15)
Number of subjects: 30
Study: 12110964

Group type: EXPERIMENTAL
Intervention: Experiment 1 - varying initial position of the limb
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Experiment 2 - matched change in position of the limb and monitor display
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Experiment 3 - fixed initial position of the limb, varying monitor display location
Number of subjects: 0
Study: 9558685

Group type: EXPERIMENTAL
Intervention: Ventricular rate stabilization (VRS) pacing
Number of subjects: 16

Group type: COMPARATOR
Intervention: VVI pacing
Number of subjects: 16
Study: 8596815

Group type: EXPERIMENTAL
Intervention: ProSol PDS 22‐4 (irrigating solution)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 30
Study: 2755712

Group type: EXPERIMENTAL
Intervention: Hypnosis treatment
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 66
Study: 31484523

Group type: EXPERIMENTAL
Intervention: PRO‐based remote follow‐up
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PRO‐based telephone consultation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual outpatient follow‐up (control group)
Number of subjects: 0
Study: 28028619

Group type: EXPERIMENTAL
Intervention: Hydrolyzed beef protein
Number of subjects: 27

Group type: COMPARATOR
Intervention: Whey protein
Number of subjects: 27

Group type: COMPARATOR
Intervention: Non-protein isoenergetic carbohydrate
Number of subjects: 27
Study: 26499250

Group type: EXPERIMENTAL
Intervention: tDCS‐working memory (DCS‐WM)
Number of subjects: 100

Group type: COMPARATOR
Intervention: tDCS‐control cognitive training (DCS‐CC)
Number of subjects: 100

Group type: COMPARATOR
Intervention: sham tDCS‐working memory (WM‐CD)
Number of subjects: 100
Study: 23255145

Group type: EXPERIMENTAL
Intervention: Topical perfluorodecalin (PFD) with R0 method (3 passes)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: R0 method (3 passes with PFD)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Single pass method
Number of subjects: 29

Group type: COMPARATOR
Intervention: R20 method
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: PFD application
Number of subjects: 29
Study: 21254315

Group type: EXPERIMENTAL
Intervention: Bright light (45 min)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Bright light (45 min/day for 4 weeks)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo treatment (4 weeks)
Number of subjects: 33
Study: 19497597

Group type: EXPERIMENTAL
Intervention: ExCHO - 80-minute resistance exercise bout while consuming CHO (approximately 77 g CHO, 306 kcal)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: ExPLA - identical exercise with a non-caloric placebo
Number of subjects: 21

Group type: COMPARATOR
Intervention: NoExCHO - no-exercise trial of quiet sitting and CHO consumption
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: All conditions
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: ExCHO and ExPLA
Number of subjects: 21
Study: 17457160

Group type: EXPERIMENTAL
Intervention: Intraoperative blood salvage (blood volume equal to approximately 0.7% of the patient's body weight collected before liver transection)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control group (no blood salvage)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Intraoperative blood salvage
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 79
Study: 15865035

Group type: EXPERIMENTAL
Intervention: Transverse coloplasty pouch (TCP)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Colon J-pouch (CJP)
Number of subjects: 106